TOP2A induces malignant character of pancreatic cancer through activating β-catenin signaling pathway
- 1 January 2018
- journal article
- research article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1864 (1) , 197-207
Abstract
No abstract availableKeywords
Funding Information
- Zhejiang Province (2017KY223)
- Zhejiang people's hospital (ZRY2016B003)
This publication has 22 references indexed in Scilit:
- A phase II study of Epirubicin in oxaliplatin-resistant patients with metastatic colorectal cancer and TOP2A gene amplificationBMC Cancer, 2016
- Topoisomerase 2 Alpha Cooperates with Androgen Receptor to Contribute to Prostate Cancer ProgressionPLOS ONE, 2015
- Topoisomerase‐1 and ‐2A gene copy numbers are elevated in mismatch repair‐proficient colorectal cancersMolecular Oncology, 2015
- The catalytic topoisomerase II inhibitor dexrazoxane induces DNA breaks, ATF3 and the DNA damage response in cancer cellsBritish Journal of Pharmacology, 2015
- Topoisomerase IIα in chromosome instability and personalized cancer therapyOncogene, 2014
- MicroRNA Alterations of Pancreatic Intraepithelial NeoplasiasClinical Cancer Research, 2012
- RECQL5 cooperates with Topoisomerase II alpha in DNA decatenation and cell cycle progressionNucleic Acids Research, 2011
- The SET and transposase domain protein Metnase enhances chromosome decatenation: regulation by automethylationNucleic Acids Research, 2008
- Functional Interaction of DNA Topoisomerase IIα With the β-Catenin and T-Cell Factor-4 ComplexGastroenterology, 2007
- Interaction between Glucose-regulated Destruction Domain of DNA Topoisomerase IIα and MPN Domain of Jab1/CSN5Journal of Biological Chemistry, 2004